Emergence of azole-resistant Candida parapsilosis causing bloodstream infection: results from laboratory-based sentinel surveillance in South Africa.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Journal of Antimicrobial Chemotherapy

• Publication date

  2016-07-01

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.1093/jac/dkw091PMID 27125552PMCID PMC11911919
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Invasive Candidiasis.

  2019cited by this paper
• Multicenter Study of Epidemiological Cutoff Values and Detection of Resistance in Candida spp. to Anidulafungin, Caspofungin, and Micafungin Using the Sensititre YeastOne Colorimetric Method

  2015cited by this paper
• Declining Incidence of Candidemia and the Shifting Epidemiology of Candida Resistance in Two US Metropolitan Areas, 2008–2013: Results from Population-Based Surveillance

  2015cited by this paper
• Population-Based Analysis of Invasive Fungal Infections, France, 2001–2010

  2014cited by this paper
• Multilaboratory Study of Epidemiological Cutoff Values for Detection of Resistance in Eight Candida Species to Fluconazole, Posaconazole, and Voriconazole

  2014cited by this paper
• ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013.

  2014cited by this paper
• Molecular Mechanisms of Fluconazole Resistance in Candida parapsilosis Isolates from a U.S. Surveillance System

  2014cited by this paper
• Use of Anidulafungin as a Surrogate Marker To Predict Susceptibility and Resistance to Caspofungin among 4,290 Clinical Isolates of Candida by Using CLSI Methods and Interpretive Criteria

  2014cited by this paper
• Candida auris–Associated Candidemia, South Africa

  2014cited by this paper
• Global trends in the distribution of Candida species causing candidemia.

  2014cited by this paper
• Use of Micafungin as a Surrogate Marker To Predict Susceptibility and Resistance to Caspofungin among 3,764 Clinical Isolates of Candida by Use of CLSI Methods and Interpretive Criteria

  2013cited by this paper
• Candida parapsilosis Is a Significant Neonatal Pathogen: A Systematic Review and Meta-analysis

  2013cited by this paper
• Epidemiological Cutoff Values for Fluconazole, Itraconazole, Posaconazole, and Voriconazole for Six Candida Species as Determined by the Colorimetric Sensititre YeastOne Method

  2013cited by this paper
• Epidemiology of Candidemia in Latin America: A Laboratory-Based Survey

  2013cited by this paper
• Candidemia among adults in Soweto, South Africa, 1990-2007.

  2013cited by this paper
• Background changing patterns of neonatal fungal sepsis in a developing country.

  2013cited by this paper
• Interlaboratory Variability of Caspofungin MICs for Candida spp. Using CLSI and EUCAST Methods: Should the Clinical Laboratory Be Testing This Agent?

  2013cited by this paper
• Comparison of Three Statistical Methods for Establishing Tentative Wild-Type Population and Epidemiological Cutoff Values for Echinocandins, Amphotericin B, Flucytosine, and Six Candida Species as Determined by the Colorimetric Sensititre YeastOne Method

  2012cited by this paper
• ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients.

  2012cited by this paper
• ESCMID* guideline for the diagnosis and management of Candida diseases 2012: prevention and management of invasive infections in neonates and children caused by Candida spp.

  2012cited by this paper
• Species Identification and Antifungal Susceptibility Testing of Candida Bloodstream Isolates from Population-Based Surveillance Studies in Two U.S. Cities from 2008 to 2011

  2012cited by this paper
• ESCMID* guideline for the diagnosis and management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT).

  2012cited by this paper
• Diagnostic Issues, Clinical Characteristics, and Outcomes for Patients with Fungemia

  2011cited by this paper
• Comparative Efficacy of Echinocandins and Nonechinocandins for the Treatment of Candida parapsilosisInfections: AMeta‐analysis

  2010cited by this paper
• Utility of a Luminex-based assay for multiplexed, rapid species identification of Candida isolates from an ongoing candidemia surveillance.

  2010cited by this paper
• Low Prevalence of fks1 Hot Spot 1 Mutations in a Worldwide Collection of Candida Strains

  2010cited by this paper
• Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.

  2009cited by this paper
• Candida species: species distribution and antifungal susceptibility patterns.

  2008cited by this paper
• A Naturally Occurring Proline-to-Alanine Amino Acid Change in Fks1p in Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis Accounts for Reduced Echinocandin Susceptibility

  2008cited by this paper
• Molecular epidemiology of candidemia: evidence of clusters of smoldering nosocomial infections.

  2008cited by this paper
• Geographic and Temporal Trends in Isolation and Antifungal Susceptibility of Candida parapsilosis: a Global Assessment from the ARTEMIS DISK Antifungal Surveillance Program, 2001 to 2005

  2008cited by this paper
• Adequacy of empirical antifungal therapy and effect on outcome among patients with invasive Candida species infections.

  2007cited by this paper
• Candida krusei, a Multidrug-Resistant Opportunistic Fungal Pathogen: Geographic and Temporal Trends from the ARTEMIS DISK Antifungal Surveillance Program, 2001 to 2005

  2007cited by this paper
• Nosocomial fungal infections: epidemiology, diagnosis, and treatment.

  2007cited by this paper
• Evaluation of Amphotericin B Interpretive Breakpoints for Candida Bloodstream Isolates by Correlation with Therapeutic Outcome

  2006cited by this paper
• Epidemiology of Candidemia in Brazil: a Nationwide Sentinel Surveillance of Candidemia in Eleven Medical Centers

  2006cited by this paper
• Comparison of the Susceptibilities of Candida spp. to Fluconazole and Voriconazole in a 4-Year Global Evaluation Using Disk Diffusion

  2003cited by this paper
• Role of Sentinel Surveillance of Candidemia: Trends in Species Distribution and Antifungal Susceptibility

  2002cited by this paper
• A two year global evaluation of the susceptibility of Candida species to fluconazole by disk diffusion.

  2000cited by this paper

• A five-year multicentre evaluation of candidaemia in UK adults; epidemiology, risk factors and outcomes.

  2026cites this paper
• Inter‐Hospital Spread of Fluconazole‐Resistant C. parapsilosis in Northern Italy: Insights Into Clonal Distribution, Resistance Mechanisms and Biofilm Production

  2025cites this paper
• Changing Climate, Changing Candida: Environmental and Social Pressures on Invasive Candidiasis and Antifungal Resistance in Latin America

  2025cites this paper
• Clinical impact of fluconazole-resistant Candida parapsilosis: a narrative review.

  2025cites this paper
• Identification and antifungal resistance profiling of Candida (Candidozyma) auris in a tertiary hospital in Istanbul, Türkiye

  2025cites this paper
• Addressing the silent threat: managing invasive Candida infections in hospitalized newborns

  2025cites this paper
• Epidemiology of Candidemia in Children and Neonates in Korea, 2009–2018: A Multi-Center Study

  2025cites this paper
• The Burden of Neonatal Invasive Candidiasis in Low- and Middle-income Countries: A Systematic Review and Meta-analysis

  2025cites this paper
• Recent Systemic Antifungal Exposure and Nonsusceptible Candida in Hospitalized Patients, South Africa, 2012–2017

  2025cites this paper
• Genotypic Diversity and Molecular Basis of Fluconazole Resistance in Candida parapsilosis Clinical Isolates Collected Over 7 Years in a Tertiary‐Care Hospital in North India

  2025cites this paper
• The S862C amino acid change in CpMrr1 confers fluconazole resistance in Candida parapsilosis

  2025cites this paper
• Pathogen aetiology and risk factors for death among neonates with bloodstream infections at lower-tier South African hospitals: a cross-sectional study

  2025cites this paper
• Antimicrobial Activity of the Peptide C14R Against Ab Initio Growing and Preformed Biofilms of Candida albicans, Candida parapsilosis and Candidozyma auris

  2025cites this paper
• Rapid Identification of Clinically Relevant Candida spp. by I-dOne Software Using Attenuated Total Reflectance Fourier Transform Infrared (ATR-FTIR) Spectroscopy

  2025cites this paper
• Mechanisms of resistance to cell wall and plasma membrane targeting antifungal drugs in Candida species isolated in Africa

  2025cites this paper
• Detection of Fluconazole Resistance in Candida parapsilosis Clinical Isolates with MALDI-TOF Analysis: A Proof-of-Concept Preliminary Study

  2025cites this paper
• Diagnosis and Management of Candidemia and Invasive Candidiasis in Neonates and Children.

  2025cites this paper
• Bacterial and fungal pathogens causing neonatal sepsis and associated antimicrobial resistance in South African neonatal units—a systematic review

  2025cites this paper
• Species Distribution and Antifungal Susceptibility of Fungal Blood Isolates over a 16-Year Period at a University Hospital.

  2025cites this paper
• Identification of Candida parapsilosis sensu lato and antifungal susceptibility testing of candidemia patients in a tertiary-care hospital in Malaysia

  2025cites this paper
• Toward inclusive microbial monitoring: The case for pathogenic yeast surveillance in South African groundwater

  2025cites this paper
• The Impact of Climate Change on Human Fungal Pathogen Distribution and Disease Incidence

  2024cites this paper
• Standardization of polymerase chain reaction for detection of fluconazole resistance targeting Y132F mutation in ERG11 gene in Candida parapsilosis

  2024cites this paper
• Fungal Infections, Treatment and Antifungal Resistance: The Sub-Saharan African Context

  2024cites this paper
• High‐Resolution Melting Assay to Detect the Mutations That Cause the Y132F and G458S Substitutions at the ERG11 Gene Involved in Azole Resistance in Candida parapsilosis

  2024cites this paper
• The Road Ahead: Advancing Antifungal Vaccines and Addressing Fungal Infections in the Post-COVID World.

  2024cites this paper
• The role of N-acetylcysteine on adhesion and biofilm formation of Candida parapsilosis isolated from catheter-related candidemia

  2024cites this paper
• Candida parapsilosis: A systematic review to inform the World Health Organization fungal priority pathogens list

  2024cites this paper
• Risk factors associated with fluconazole resistance in Candida parapsilosis candidemia: A case–case study

  2024cites this paper
• In Vitro Susceptibility Tests in the Context of Antifungal Resistance: Beyond Minimum Inhibitory Concentration in Candida spp.

  2023cites this paper
• Incidence, Species Distribution, and Antifungal Susceptibility of Candida Bloodstream Infections in a Tertiary Algerian Hospital

  2023cites this paper
• Paradigm Shift: Candida parapsilosis sensu stricto as the Most Prevalent Candida Species Isolated from Bloodstream Infections with Increasing Azole-Non-Susceptibility Rates: Trends from 2015–2022 Survey

  2023cites this paper
• Candida auris Clinical Isolates Associated with Outbreak in Neonatal Unit of Tertiary Academic Hospital, South Africa

  2023cites this paper
• Clinical, Epidemiological and Laboratory Features of Invasive Candida parapsilosis Complex Infections in a Brazilian Pediatric Reference Hospital during the COVID-19 Pandemic

  2023cites this paper
• Candida parapsilosis sensu stricto Antifungal Resistance Mechanisms and Associated Epidemiology

  2023influential citation
• Epidemiology and susceptibility of Nakaseomyces (formerly Candida) glabrata bloodstream isolates from hospitalised adults in South Africa.

  2023cites this paper
• Species Distribution and Antifungal Susceptibilities of Candida Species Isolated From Blood Culture

  2023cites this paper
• Improving the Detection of Epidemic Clones in Candida parapsilosis Outbreaks by Combining MALDI-TOF Mass Spectrometry and Deep Learning Approaches

  2023cites this paper
• Emergence and circulation of azole-resistant C. albicans, C. auris and C. parapsilosis bloodstream isolates carrying Y132F, K143R or T220L Erg11p substitutions in Colombia

  2023cites this paper
• Candida parapsilosis Cell Wall Proteome Characterization and Effectiveness against Hematogenously Disseminated Candidiasis in a Murine Model

  2023cites this paper
• Neonatal invasive candidiasis in low- and middle-income countries: Data from the NeoOBS study

  2023cites this paper
• Risk Factors and Characteristics of Candidemia After Cardiac Surgery in Pediatric Patients in Central Israel

  2023cites this paper
• Epidemiology, risk factors and outcomes associated with candidaemia in very low birth weight infants at a tertiary South African Hospital over a 7-year period (2013–2019)

  2023cites this paper
• Candidiasis and Other Emerging Yeasts

  2023cites this paper
• Global Emergence of Resistance to Fluconazole and Voriconazole in Candida parapsilosis in Tertiary Hospitals in Spain During the COVID-19 Pandemic

  2022cites this paper
• Non-albicans Candida Species: Immune Response, Evasion Mechanisms, and New Plant-Derived Alternative Therapies

  2022cites this paper
• Antifungal Effect and Inhibition of the Virulence Mechanism of D-Limonene against Candida parapsilosis

  2022cites this paper
• Recent advances and challenges in the early diagnosis and management of invasive fungal infections in Africa.

  2022cites this paper
• Emerging and re‐emerging fungal threats in Africa

  2022cites this paper
• Early detection of Candida parapsilosis in peripheral blood as a result of a peripheral blood smear performed after cytographic changes on the Beckman Coulter UniCel DxH 800 hematology

  2022cites this paper
• Pan-Echinocandin Resistant C. parapsilosis Harboring an F652S Fks1 Alteration in a Patient with Prolonged Echinocandin Therapy

  2022cites this paper
• Characterisation of Candida parapsilosis CYP51 as a Drug Target Using Saccharomyces cerevisiae as Host

  2022cites this paper
• Increasing Incidence and Shifting Epidemiology of Candidemia in Greece: Results from the First Nationwide 10-Year Survey

  2022cites this paper
• Candidemia among Hospitalized Pediatric Patients Caused by Several Clonal Lineages of Candida parapsilosis

  2022cites this paper
• Incidence of candidemia and prevalence of azole-resistant candidemia at a tertiary South African hospital – A retrospective laboratory analysis 2016–2020

  2022cites this paper
• Antifungal drug resistance: an update

  2022cites this paper
• Commercial Methods for Antifungal Susceptibility Testing of Yeasts: Strengths and Limitations as Predictors of Resistance

  2022cites this paper
• Fluconazole-resistant Candida parapsilosis clonally related genotypes: first report proving the presence of endemic isolates harbouring the Y132F ERG11 gene substitution in Spain.

  2022cites this paper
• Global Prevalence of Antifungal-Resistant Candida parapsilosis: A Systematic Review and Meta-Analysis

  2022cites this paper
• Determinants of fluconazole resistance and the efficacy of fluconazole and milbemycin oxim combination against Candida parapsilosis clinical isolates from Brazil and Turkey

  2022cites this paper
• Culture-confirmed neonatal bloodstream infections and meningitis in South Africa, 2014–19: a cross-sectional study

  2022cites this paper
• Characterization and functional analysis of zinc trafficking in the human fungal pathogen Candida parapsilosis

  2022cites this paper
• Clade distribution of Candida auris in South Africa using whole genome sequencing of clinical and environmental isolates

  2021cites this paper
• Hospital Outbreak of Fluconazole-Resistant Candida parapsilosis: Arguments for Clonal Transmission and Long-Term Persistence

  2021cites this paper
• Neonatal sepsis in a tertiary unit in South Africa

  2021cites this paper
• Prevalence and Antifungal Susceptibility of Candida parapsilosis Species Complex in Eastern China: A 15-Year Retrospective Study by ECIFIG

  2021cites this paper
• Ibrexafungerp: A First-in-Class Oral Triterpenoid Glucan Synthase Inhibitor

  2021cites this paper
• Trends towards lower azole susceptibility among 200 Candida tropicalis bloodstream isolates from Brazilian Medical Centers.

  2021cites this paper
• Epidemiology of Culture-confirmed Candidemia Among Hospitalized Children in South Africa, 2012–2017

  2021cites this paper
• Antimicrobial Peptides Pom-1 and Pom-2 from Pomacea poeyana Are Active against Candida auris, C. parapsilosis and C. albicans Biofilms

  2021cites this paper
• Species distribution, azole resistance and related molecular mechanisms in invasive Candida parapsilosis complex isolates: Increase in fluconazole resistance in 21 years

  2021cites this paper
• HIV Infection as Risk Factor for Death among Hospitalized Persons with Candidemia, South Africa, 2012–2017

  2021cites this paper
• Resistance to Antifungal Drugs.

  2021cites this paper
• Genetic Manipulation as a Tool to Unravel Candida parapsilosis Species Complex Virulence and Drug Resistance: State of the Art

  2021cites this paper
• Two different clones of Candida pelliculosa bloodstream infection in a tertiary neonatal intensive care unit.

  2021cites this paper
• Collateral consequences of agricultural fungicides on pathogenic yeasts: A One Health perspective to tackle azole resistance

  2021cites this paper
• Elderly versus nonelderly patients with invasive fungal infections: species distribution and antifungal resistance, SENTRY antifungal surveillance program 2017-2019.

  2021cites this paper
• Lung nodules due to Candida parapsilosis in a person with cystic fibrosis

  2021cites this paper
• Species Diversity of Candida from Hospital Environment in Plateau State, Nigeria

  2020cites this paper
• Screening for invasive fungal disease using non‐culture‐based assays among inpatients with advanced HIV disease at a large academic hospital in South Africa

  2020cites this paper
• Fluconazole‐resistant Candida parapsilosis strains with a Y132F substitution in the ERG11 gene causing invasive infections in a neonatal unit, South Africa

  2020cites this paper
• Changing epidemiology of candidaemia: Increase in fluconazole‐resistant Candida parapsilosis

  2020cites this paper
• Genetically related micafungin-resistant Candida parapsilosis blood isolates harbouring novel mutation R658G in hotspot 1 of Fks1p: a new challenge?

  2020cites this paper
• Candida parapsilosis endocarditis. Report of cases and review of the literature.

  2020cites this paper
• Change in species distribution and antifungal susceptibility of candidemias in an intensive care unit of a university hospital (10-year experience)

  2020cites this paper
• The Quiet and Underappreciated Rise of Drug-Resistant Invasive Fungal Pathogens

  2020cites this paper
• First Report of Candidemia Clonal Outbreak Caused by Emerging Fluconazole-Resistant Candida parapsilosis Isolates Harboring Y132F and/or Y132F+K143R in Turkey

  2020cites this paper
• Prevalence and Antifungal Susceptibility of Pathogenic Yeasts in China: A 10-Year Retrospective Study in a Teaching Hospital

  2020cites this paper
• Prevalence and Clonal Distribution of Azole-Resistant Candida parapsilosis Isolates Causing Bloodstream Infections in a Large Italian Hospital

  2020influential citation
• Evaluation of Molecular Epidemiology, Clinical Characteristics, Antifungal Susceptibility Profiles, and Molecular Mechanisms of Antifungal Resistance of Iranian Candida parapsilosis Species Complex Blood Isolates

  2020influential citation
• AN OUTBREAK OF CANDIDEMIA AMONG HOSPITALIZED NEONATES AT TI- KUR ANBESSA SPECIALIZED TEACHING HOSPITAL: A CALL FOR INCREASED AWARENESS

  2020cites this paper
• Multilocus sequence typing of azole-resistant Candida auris strains, South Africa

  2020cites this paper
• Comparative in vitro activities of seven antifungal drugs against clinical isolates of Candida parapsilosis complex.

  2020cites this paper
• Efficacy of LAMB against Emerging Azole- and Multidrug-Resistant Candida parapsilosis Isolates in the Galleria mellonella Model

  2020cites this paper
• Decreasing fluconazole susceptibility of clinical South African Cryptococcus neoformans isolates over a decade

  2020cites this paper
• Drug-Resistant Fungi: An Emerging Challenge Threatening Our Limited Antifungal Armamentarium

  2020cites this paper
• First multicenter report of in vitro resistance rates in candidemia isolates in Turkey.

  2019cites this paper
• Candida parapsilosis: from Genes to the Bedside

  2019cites this paper
• Emergence of clonal fluconazole-resistant Candida parapsilosis clinical isolates in a multicentre laboratory-based surveillance study in India

  2019cites this paper
• Development of fungal identification tools and evaluation of microbiological and clinical profiles of Candida species from Iran

  2019cites this paper